Inventor

MONTAGNIER LUC

FR123 patents

⚠️ This page may combine multiple inventors who share the name “MONTAGNIER LUC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MONTAGNIER LUC

PASTEUR INSTITUT

Human immunodeficiency viruses associated with Acquired Immune Deficiency Syndrome (AIDS), a diagnostic method for AIDS and pre-AIDS, and a kit therefor

Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes

Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays

Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2

Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits

Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits

Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2)

Peptides related to human immunodeficiency virus II (HIV-2)

Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses

Nucleotide sequences derived from the genome or retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses

Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the disease due to these viruses

In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies

Methods and kits for the detection of human immunodeficiency virus type 2 employing HIV-2 specific antibodies and antigens

Methods, kits, and probes for diagnosing HIV-2

In vitro diagnostic assays for the detection of HIV-1 or HIV-2 employing viral-specific antigens and antibodies

DNA fragments obtained from a novel human immunodeficiency virus designated LAVMAL

Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes

Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2

DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2

Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2)

HIV-2 antigen compositions

Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby

Human Immunodeficiency Virus (HIV) associated with Acquired Immunual Deficiency Syndrome (AIDS), a diagnostic method for aids and pre-aids, and a kit therefor

Retrovirus capable of causing AIDS, means and method for detecting it in vitro

Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80)

Methods and kits for detecting antibodies against an HIV variant

Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins

Diagnostic method and composition for early detection of HIV infection

HIV-2 transmembrane glycoprotein homodimer (GP 80)

Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens

Antibodies which bind with proteins of human immunodeficiency virus type 1 (HIV-1), and immune complexes comprising proteins of HIV-1

Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80

Variant of LAV viruses

Variant of LAV viruses

Peptide comprising the sequence CAFRQVC and methods using it

Cloned dna sequences related to the entire genomic rna of human immunodeficiency virus ii (hiv-2), polypeptides encoded by these dna sequences and use of these dna clones and polypeptides in diagnostic kits

Methods and kits for detecting antibodies against an HIV variant

Kits for the detection of human immunodeficiency virus type 2 (HIV-2) antigens

In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies

Variant of LAV viruses

Nucleic acids encoding peptides of the envelope region of HIV-2 and peptides, polypeptides, and methods for producing the peptides and polypeptides of the HIV-2 envelope gene

MONTAGNIER LUC

System and method for the analysis of DNA sequences in biological fluids

System and method for the analysis of DNA sequences in biological fluids

Detection of DNA sequences as risk factors for HIV infection

System and method for the analysis of DNA sequences in biological fluids

System and method for the analysis of DNA sequences in biological fluids

TRANSGENE SA

Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.

Viral vector coding glycoprotein of HIV-1

(unassigned)

Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)

INST NAT SANTE RECH MED

Nucleotide sequences derived from the genome of retroviruses of the hiv-1, hiv-2 and siv type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses